期刊文献+

抗EV71病毒人源抗体Fab段表达基因的构建及序列分析 被引量:1

Construction and sequence analysis of expression cassette for Fab fragments of human-origin immunoglobulin against EV71
下载PDF
导出
摘要 目的从成人外周血淋巴细胞中扩增抗体可变区并构建人源抗体Fab段表达基因,为构建抗EV71病毒人源化单克隆抗体库奠定基础。方法从EV71病毒中和抗体阳性且免疫功能健全的成人全血中,分离淋巴细胞并提取总RNA,经反转录获得cDNA。用一组人IgG Fab基因特异性引物,从合成的cDNA中分别扩增抗体轻、重链可变区,应用重叠PCR技术构建Fab段表达基因,测序分析抗体基因的多样性。结果成功扩增人抗体可变区基因并组装Fab段表达盒,表达盒的长度约为1 500bp,测序分析结果表明,Fab段的多样性可达94.12%。结论成功构建人源抗体Fab段基因,为抗EV71病毒人源性单克隆抗体库的制备奠定了基础。 Humanized monoclonal antibodies against enterovirus type 71 (EV7 t) are ideal options in clinical treatment of EV71 infections. In this study, variable region genes of human-origin immunoglobulin were amplified to construct recombinant Fah fragments against EVT1. Total RNA was extracted from peripheral blood [ymphocytes of a normal adult that was positive with EV71 neutralizing antibody. With the reverse-transcribed cDNAs as templates, variable region genes of light and heavy chains were amplified by human IgG antihody primer sets, and the expression cassettes for Fab fragments were subsequently constructed by splicing by overlap extension PCR (SOE-PCR). It was indicated by sequence analysis of obtained 1 500 bp ampl- icons that diversity in Fab fragments was 94. 12 %, suggesting successful construction of a Fab fragment expression library, which facilitated preparation of human-origin monoclonal antibody library against EV71.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2014年第3期234-238,共5页 Chinese Journal of Zoonoses
基金 福建省自然科学基金项目(No.2010J01115) "863"计划重点项目(2011AA02A114)经费资助~~
关键词 肠道病毒71型 人源化 单克隆抗体 FAB enterovirus 71 humanization, monoclonal antibodies Fab
  • 相关文献

参考文献16

  • 1Chatproedprai S, Theanboonlers A, Korkong S, et al. Clincal and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008-2009[J]. Jpn J Infect Dis, 2010, 63(4): 229- 233.
  • 2李欢,李薇.肠道病毒71型疫苗的研究进展[J].微生物学免疫学进展,2012,40(2):89-94. 被引量:10
  • 3Robert R, Lefranc MP, Ghochikyan A, et al. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-tenninal immunodominant epitope of the amyloid[3peptide [J]. Mol Immunol, 2010, 48(1/3) 59-72. DOI 10. 1016/j. molimm. 2010.09. 012.
  • 4Andris-Widhopf J, Steinberger P, Fuller R, et al. Generation of human Fab antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequences[J]. Cold Spring Har- bor Protocols, 2011, 2011(9): 1151-1165. DOI: i0. llOl/pdb. prot065565.
  • 5National Polio and Measles Laboratory. Hand-foot-and-mouthDisease Laboratory Manual[R]. Beijing Chinese Center for Disease Control and Prevention, 2010: 20-26. (in Chinese).
  • 6Kohler G, Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity[J]. Nature, 1975, 256(5517) : 495-497.
  • 7陈立慧,宋海峰,刘秀文.治疗性人源化单克隆抗体研究进展[J].中国新药杂志,2004,13(7):590-594. 被引量:10
  • 8Fox KM, Dias JA, Van Roey P. Three-dimensional structure of human follicle-stimulating hormone[J-]. Mol Endocriol, 2001, 15(3): 378-389. DOI 10.1210/me. 15.3.378.
  • 9Furuse M, Hata M, Furuse K, et al. Claudin-based tightjunc- tions are crucial for the mammalian epidermal barrier: alesson from claudin-deficient mice [J]. J Cell BioI, 2002, 156 ( 6 ) : 1099-1111. DOI: i0. 1083/jcb. 200110122.
  • 10苏雪莹,赵振富,徐杰,汪华侨,初国良.人源性老年痴呆单链噬菌体抗体库的构建[J].中国老年学杂志,2011,31(17):3294-3297. 被引量:1

二级参考文献84

  • 1张革,汪华侨,邹俊涛,李国营,袁群芳,林贤,姚志彬,张革.Aβ_(1-15)多价DNA疫苗的构建及其对体液免疫的效果[J].中山大学学报(医学科学版),2005,26(4):371-376. 被引量:5
  • 2王晋,罗文新,李利峰,陈瑛炜,王明桥,张军,夏宁邵.多样性人源天然噬菌体抗体库的构建及初步应用[J].细胞与分子免疫学杂志,2006,22(6):786-789. 被引量:5
  • 3[1]Hughes D. Therapeutic antibodies make a comeback [ J ]. Drug Discovery Today, 1998,3(10): 439 - 442.
  • 4[2]Mclaughlin P. Rituximab: perspective on single agent experience,and future directions in combination trials [ J ]. Crit Rev Oncol/Hemat ,2001,40(10) :3- 16.
  • 5[4]Colomer R, Shamon LA, Tsai MS, et al. Herceptin: from the bench to the clinic [ J ]. Cancer Invest, 2001,19( 1 ) :49 - 53.
  • 6[5]Bucbler P, Reber HA. Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (Herceptin) [ J ]. J Gastrointestinal Surg ,2001,5(2): 139 - 146.
  • 7[7]Mavromatis B, Cheson BD. Monoclonal antibody therapy of chronic lymphocytic leukemia [ J ]. J Clin Oncol, 2003,21 ( 9 ):1874 - 1881.
  • 8[8]Goldenberg DM. The role of radiolabeled antibodies in the treatment of non-Hodgkin' s lymphoma: the coming of age of radioimmunotherapy[ J ]. Criti Rev Oncol/Hemat, 2001,39 (7 - 8 ):195 - 201.
  • 9[9]Kim JA. Targeted therapies for the treatment of cancer[J]. Am J Surg, 2003,186 (9): 264 - 268.
  • 10[10]Woodle ES,Bluestone JA,Zivin RA, et al. Humanized nonmitogenic OKT3γ antibody, huOKT3 (Ala-Ala) :initial clinical experience[J]. Transplant Proc, 1998,30(4): 1369 - 1370.

共引文献25

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部